TIGIT and PD-1 expression atlas predicts response to adjuvant chemotherapy and PD-L1 blockade in muscle-invasive bladder cancer.

Zhaopei LiuHan ZengKaifeng JinYanze YuRunze YouHongyi ZhangChunnan LiuXiaohe SuSen YanYuan ChangLi LiuLe XuJiejie Xu Yu Zhu Zewei Wang

Published in: British journal of cancer (2022)

TIGIT/PD-1-based risk stratification with distinct immune and molecular features could be served as a predictor for systematic therapeutic response including adjuvant chemotherapy and immunotherapy in MIBC patients.

Keyphrases

muscle invasive bladder cancer
end stage renal disease
newly diagnosed
chronic kidney disease
poor prognosis
prognostic factors
single molecule